EU regulator backs Eisai-Biogen Alzheimer's drug

European committee takes a second look at Alzheimer's drug and now says it should be approved
A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting the drug. Biogen said Thursday that the drug, known in the U.S. as Leqembi,
Changing course, European regulators now say Alzheimer’s treatment Leqembi should be approved
Reversing an earlier decision, European regulators recommended that an Alzheimer’s therapy from Eisai and Biogen should be approved.
EU regulator backs Eisai-Biogen Alzheimer's drug after initial rejection
The European Union's drugs regulator on Thursday recommended approval for Eisai and Biogen's Leqembi in some patients with early Alzheimer's disease, nearly four months after it first rejected the treatment.
EU regulator reverses decision to block Alzheimer's drug lecanemab
The European Union's drugs regulator reversed its decision to block the Alzheimer's drug lecanemab, a treatment aimed at slowing cognitive decline in patients. In July, the Amsterdam-based European Medicines Agency (EMA) denied recommending approval of the drug made by Eisai and Biogen because it considered the risks - especially bleeding and swelling in the brain - to be greater than the potential benefits in a broad population.
European Watchdog Partially Approves New Alzheimer's Drug
Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer's disease, reversing an earlier decision not to give it the green light.
EU drugs regulator recommends Alzheimer's drug from Eisai-Biogen
The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with early Alzheimer's disease, months after the agency first rejected the treatment.

Europe, Ukraine

Exclusive: European powers pushing for resolution against Iran at IAEA, diplomats say
The resolution would task the IAEA with issuing a "comprehensive report" on Iran's nuclear activities, which would put ...
Hosted on MSN13h
Long-end US bond yields, European shares rise with dollar; bitcoin above $90K
LONDON (Reuters) -Longer-dated U.S. bond yields rose alongside the dollar on Thursday as investors bet that President-elect ...
Politico Europe5h
Here’s the timeline for the new European Commission
European Parliament lawmakers have put Ursula von der Leyen’s 26 commissioner nominees through the wringer for nearly 80 ...
Blinken heads to Brussels as European diplomats brace for four more years of Trump
Secretary of State Antony Blinken heads to Brussels Tuesday as President-elect Donald Trump’s possible moves on support for ...
European fake art network involving Banksys, Warhols, Modiglianis uncovered in Italy
Italian authorities say they have dismantled a network of European art forgers who made fake Warhols, Banksys and Picassos ...
European Soccer Rocked by Two Antisemitic Attacks in One Week
It was reported that some of the players, aged 13, were spat on during the game as well as allegedly being threatened with ...
CBS News on MSN3d
European agency says 2024 is "virtually certain" to be warmest year on record
Climate scientists working at the European Union's Copernicus Climate Change Service have announced that 2024 is "virtually ...
European countries are spending more on defense, a think tank says
European nations have boosted their defenses in response to the annexation of the Crimea Peninsula in 2014 and Russia’s ...
Ludivine Sagnier to Serve on European Shooting Stars Jury, Alongside Director Radu Muntean, Producer Amel Soudani
He is joined by Swiss producer Amel Soudani, founder of the production company AMKA Films Productions. Her most recent ...
It’s time European investors capitalized on Dubai’s green investment opportunities
Investor David von Rosen explains why European investors should tap into Dubai's environmental, social and governance (ESG) ...